Abstract Purpose of Review Despite its promise as an HIV prevention strategy, PrEP uptake
remains slow, especially among highest priority populations. One factor that may be …

Introduction Oral pre-exposure prophylaxis (PrEP) is an effective strategy to reduce the risk
of HIV transmission in high risk individuals. However, the effectiveness of oral pre-exposure …

Background Antiretroviral chemoprophylaxis before exposure is a promising approach for
the prevention of human immunodeficiency virus (HIV) acquisition. Methods We randomly …

Background While the introduction of HIV Pre-Exposure Prophylaxis (PrEP) as an HIV
prevention strategy has allowed women to exercise more control over the reduction of HIV …

Introduction Stigma and disclosure concerns have been key barriers to oral pre‐exposure
prophylaxis (PrEP) adherence for African adolescent girls and young women (AGYW) in …

In this Series paper, we review evidence on the co-occurring and synergistic epidemics
(syndemic) of HIV and mental health problems worldwide among men who have sex with …

Daily oral pre-exposure prophylaxis (PrEP) is the use of antiretroviral drugs by HIV-negative
people to prevent HIV infection. WHO released new guidelines in 2015 recommending PrEP …

Following recommendations by the World Health Organization in 2015, and key clinical
trials, countries in sub-Saharan Africa, the region with the highest burden of human …

Pre-exposure prophylaxis (PrEP) is a new biomedical intervention for HIV prevention. This
study systematically reviews the acceptability of PrEP among men who have sex with men …

Background In VOICE, a multisite HIV pre-exposure prophylaxis (PrEP) trial, plasma drug
levels pointed to widespread product nonuse, despite high adherence estimated by self …